Accumulating data indicate that IL-1β activates 2 major downstream effectors, the NF-κB and MAPK pathways, to stimulate the expression of adhesion molecules such as ICAM1 and VCAM1 in diverse cell types including tumor cells, thereby amplifying and sustaining responses to IL-1β (54). This evidence concerns the gene NFKB1 and neoplasm.